Our Technology, Next-Generation Sequencing (NGS) can track COVID-19 transmission and viral mutations, inform testing protocols and infection control measures, and Covid-19 Surveillance and Outbreaks.

NGS is paving the way towards personalized medicine!
NGS has the potential to accelerate the detection of disorders and generate personalized pharmacogenomics profiles.

As technology advances, NGS has the potential to make the future of genome sequencing an integral aspect of personalized medicine. The sensitivity and specificity of genetically characterizing tumor cells in patients have profound implications regarding treatment choices and predicting potential responses. 

Our Laboratory Innovation has enabled clinicians to better understand the genetic mechanisms linked to conditions in areas such as women’s health or in diseases like cancer and infectious disease. More importantly, these advances have given rise to improved diagnostics in the clinic for early intervention and monitoring treatment response, ensuring patients get the best therapies possible. Compared to first-generation sequencing and other popular diagnostic methods that are expensive and laborious, NGS has become widely accepted as the best tool for identifying subtle genetic differences in disease.